| US Startup Jacks Up Price of Life Saving Cancer Drug by 1400% |
| Written by <a href="index.php?option=com_comprofiler&task=userProfile&user=33791"><span class="small">teleSUR</span></a> |
| Thursday, 28 December 2017 14:17 |
|
Excerpt: "The potentially life-saving medicine is used to treat patients suffering from brain tumors and Hodgkin's lymphoma."
US Startup Jacks Up Price of Life Saving Cancer Drug by 1400%28 December 17
While originally sold by Bristol-Myers Squib for decades under the brand name CeeNU for about US$50 a capsule, it now goes for US$768 per pill, thanks to startup NextSource’s price hikes. According to Henry S. Friedman, a professor of neurosurgery at Duke University School of Medicine, NextSource has engaged in “price-gouging”, telling the Wall Street Journal, "People are not going to be able to afford it, or they're going to pay a lot of money and have financial liability.” The medicine is used to treat patients suffering from brain tumors and Hodgkin's lymphoma, and can be potentially life-saving. NextSource CEO Robert DiCrisci has justified the gargantuan price hikes by saying it sets the price based on the costs it incurs in developing the medication. |
he price of the cancer drug lomustine has soared to nearly 1400 percent since 2013, after it was bought by a startup in Miami, U.S.